Showing results (1671-1680 of 3,793) with videos related to

Sort By:
Pageof 380
Oncoimmunology|June 5, 2013
The immunological identity of tumor: Self implicationsJason Miska, Priyadharshini Devarajan, Zhibin Chen
Oncoimmunology|June 5, 2013
Toward the next generation of NK cell-based adoptive cancer immunotherapyJing Ni, Matthias Miller, Ana Stojanovic, et al.
Oncoimmunology|June 5, 2013
Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltrationNiels Halama, Anna Spille, Tina Lerchl, et al.
Oncoimmunology|February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancerFlorian Posch, Karina Silina, Sebastian Leibl, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Oncoimmunology|December 7, 2017
Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancerAlberto Malesci, Paolo Bianchi, Giuseppe Celesti, et al.
Oncoimmunology|December 7, 2017
Tumor-targeted costimulation with antibody-fusion proteins improves bispecific antibody-mediated immune response in presence of immunosuppressive factorsSabrina Sapski, Nadine Beha, Roland Kontermann, et al.
Oncoimmunology|December 7, 2017
Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesiclesVanesa G Martinez, Sadhbh O'Neill, Josephine Salimu, et al.
Oncoimmunology|December 7, 2017
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indicationsMariona Cabo, Rienk Offringa, Laurence Zitvogel, et al.
Oncoimmunology|January 4, 2018
The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinomaLennart Lenk, Maren Pein, Olga Will, et al.
Pageof 380